Drugs / IL-2-B-CLL
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00078520 Background | Jan 2003 → Mar 2010 | B-cell chronic lymphocytic leukemia | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-2-B-CLL | “IL-2-B-CLL 2 x 10\^7; CD40L-B-CLL 0” NCT00078520 ↗ |